Elevated expression for transcripts IGFBP2 and LGALS1 in cells at the tumor periphery (GBM-LE region) indicate aberrant ECM remodeling at the invasive GBM edge (Fig. 8G). The gene discussed is IGFBP2; the disease is glioblastoma.